Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06418672 · ClinicalTrials.gov registry record · NA
Go Sun Smart Georgia Evaluation
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 312
- Enrollment target
NCT06418672: Completed NA study, sponsored by Emory University.
NCT06418672 is a NA study that has completed, run by Emory University. The registered enrollment target is 312 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06418672, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 312 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate the dissemination of the Go Sun Smart Georgia (GSSG) program with Georgia worksites and learn whether the intervention changes the employees' sun protection behavior in outdoor workers in Southwest Georgia. The primary aim is to assess program effectiveness by comparing employee sun protection practices between the employers assigned to the GSSG intervention and the employers assigned to the wait-list control group (delayed intervention). The hypothesis that will be tested is that compared to the delayed intervention group, employees at intervention worksites will practice more sun protection during the post-test. Worksites will be asked to complete internal coach training and participate in technical assistance around sun safety. Study participants will fill out surveys and participate in interviews
Primary Outcome
Will be captured through outdoor worker survey (posttest). To evaluate the impact of GSSG on sun safety behaviors (primary outcome), employees will report a) frequency of sun protection at work (i.e., sunscreen with SPF 30+, long-sleeved shirts, long pants, hat with wide-brim, sunglasses, shade use, limit midday sun exposure, and have sunscreen, hat and eye protection at all times \[1=never, 5=always\]) and b) sunburn in past 3 months on the job (yes/no; number). Surveys will include questions
Interventions
- BEHAVIORAL Go Sun Smart Georgia (GSSG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2024-05-06 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
What the finished NCT06418672 record still lists
NCT06418672 is an interventional study that assigns participants to a tested intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which Go Sun Smart Georgia (GSSG) is the first listed.
NCT06418672 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06418672 about?
NCT06418672 is a clinical study titled "Go Sun Smart Georgia Evaluation". The goal of this clinical trial is to evaluate the dissemination of the Go Sun Smart Georgia (GSSG) program with Georgia worksites and learn whether the intervention changes the employees' sun protection behavior in outdoor workers in Southwest Georgia. The primary aim is to assess program effectiv...
What is the current status of trial NCT06418672?
This trial is currently completed. It is a NA study. The enrollment target is 312 participants. The study started on 2024-05-06. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT06418672?
The interventions under investigation include: Go Sun Smart Georgia (GSSG) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06418672?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06418672's enrollment target sits among peer trials
312 323rd of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI